Trial Identifier: | D168AC00002 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03138356 |
Start Date: | May 2017 |
Primary Completion Date: | November 2017 |
Study Completion Date: | November 2017 |
Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Translation | |
English Translation |
Country | Location |
---|---|
United Kingdom | Harrow, United Kingdom, HA1 3UJ |